FDA Approves First CRISPR Treatment in U.S.
It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier first described a new way to edit genes, called CRISPR, in a scientific paper. The discovery is so game-changing that the pair earned the Nobel Prize in Chemistry in 2020 for how it could transform the way genetic diseases are treated. Now, on Dec. 8, the U.S. Food and Drug Administration (FDA) approved the very first treatment in the country based on the technology.
[time-brightcove not-tgx=”true”]
In the medical world, that’s lightning speed. “It’s incredible,” says Doudna, professor of chemistry a...
Source: TIME: Health - December 8, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Does Testosterone Replacement Therapy Improve Anemia in Male Hypogonadism? Does Testosterone Replacement Therapy Improve Anemia in Male Hypogonadism?
A new study finds potential new benefit associated with testosterone replacement therapy.Medscape Education Clinical Briefs (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - December 8, 2023 Category: Internal Medicine Tags: Diabetes & Endocrinology Clinical Brief Source Type: news
Roche ’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone1The inavolisib combination has the potential to address resistance to treatment and poor prognosis associated with PIK3CA mutations2-5These new data are being presented today in an oral presentation at the 2023 San Antonio Breast Cancer Symposium and shared with health authoritiesBasel, 8 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) presented today positive results from the Phase III INAVO120 study evaluating inavolisib in combination with palbociclib (Ibrance ®) and fu...
Source: Roche Media News - December 8, 2023 Category: Pharmaceuticals Source Type: news
Roche ’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone1The inavolisib combination has the potential to address resistance to treatment and poor prognosis associated with PIK3CA mutations2-5These new data are being presented today in an oral presentation at the 2023 San Antonio Breast Cancer Symposium and shared with health authoritiesBasel, 8 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) presented today positive results from the Phase III INAVO120 study evaluating inavolisib in combination with palbociclib (Ibrance ®) and fu...
Source: Roche Investor Update - December 8, 2023 Category: Pharmaceuticals Source Type: news
Underdiagnosed: Anemia in Pregnancy Underdiagnosed: Anemia in Pregnancy
Clinicians should screen patients who are pregnant for iron deficiency anemia, experts said.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 30, 2023 Category: Cardiology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Days Before Surgery, Clerical Error Cuts Off Patient's Insurance
(MedPage Today) -- The day her Medicaid coverage ended, Beverly Likens was in the hospital after a scary trip to the emergency room.
The Kentucky resident was diagnosed with severe anemia and given a blood transfusion after her hemoglobin levels... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 26, 2023 Category: American Health Source Type: news
Medicines for four rare diseases become cheaper due to domestic production
Drugs for four of these diseases -Tyrosinemia Type 1, Gaucher's Disease, Wilson's Disease and Dravet-Lennox Gastaut Syndrome - along with sickle cell Anemia have been approved and are being manufactured indigenously. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 25, 2023 Category: Pharmaceuticals Source Type: news
EXCLUSIVE: Woman, 21, needs a life-saving blood transfusion after vaping ONCE caused 'acute chest syndrome'
The woman, who was from India, started to suffer pain in her back and ribs shortly after using the vape. She suffered from sickle cell anemia, which raises the risk of complications with vapes. (Source: the Mail online | Health)
Source: the Mail online | Health - November 23, 2023 Category: Consumer Health News Source Type: news
Your tiredness may be a sign of anemia. These iron-rich foods can help.
If you suspect that you’re low in iron, such as fatigue, shortness of breath, and cold hands or feet, see your health-care provider before taking action. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 20, 2023 Category: Consumer Health News Authors: Sharon Liao Source Type: news
Crispr Therapeutics (NASDAQ:CRSP) Notches Up on World-First Therapy - TipRanks.com
Great news emerged out of biotech stock Crispr Therapeutics (NASDAQ:CRSP), particularly for those who suffer from sickle-cell anemia. A new treatment for the disease was created using the genetic modification tool, and it’s given Crispr stock a boost, up nearly 5% in Tuesday morning’s trading…#crisprtherapeutics #unitedkingdom #exacel #samarthkulkarni #moderatebuy #crsp #holds (Source: Reuters: Health)
Source: Reuters: Health - November 17, 2023 Category: Consumer Health News Source Type: news
Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval
The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient. (Source: NYT Health)
Source: NYT Health - November 17, 2023 Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Genetics and Heredity Genetic Engineering Blood Bone Marrow Hemoglobin Crispr (DNA) Drugs (Pharmaceuticals) CRISPR Therapeutics Vertex Pharmaceuticals Inc Source Type: news
CRISPR Therapy Gets U.K. Approval, the First in the World
Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.
[time-brightcove not-tgx=”true”]
In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020.
The agency approved the treatment for patients with sickle cell disease and thalassemia who are 12 years old and over. Casgevy is made by Vertex ...
Source: TIME: Health - November 16, 2023 Category: Consumer Health News Authors: MARIA CHENG / AP Tags: Uncategorized Drugs wire Source Type: news
Why Am I Always So Tired?
WebMD explains conditions that might cause you to feel sluggish during the day, such as anemia, thyroid trouble, sleep apnea, diabetes, heart disease, depression, and menopause. (Source: WebMD Health)
Source: WebMD Health - November 15, 2023 Category: Consumer Health News Source Type: news
AHA: No Real Benefit Seen for Liberal Transfusion Strategy in AMI, Anemia
TUESDAY, Nov. 14, 2023 -- For patients with acute myocardial infarction and anemia, a liberal transfusion strategy does not significantly reduce the risk for recurrent myocardial infarction or death compared with a restrictive strategy, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2023 Category: Pharmaceuticals Source Type: news
In MI With Anemia, Results May Favor Liberal Transfusion In MI With Anemia, Results May Favor Liberal Transfusion
Although the primary outcome was not statistically different between a liberal and more restrictive transfusion strategy, secondary results suggest some advantages for the liberal approach.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 11, 2023 Category: Internal Medicine Tags: Cardiology News Source Type: news
